{"podcast":{"title":"Advances in Care","slug":"advances-in-care-6039100","podcast_index_feed_id":6039100,"rss_url":"https://feeds.simplecast.com/TZu4B0z0","website_url":"https://advances-in-care.simplecast.com","image_url":"https://image.simplecastcdn.com/images/28227570-5d93-44b2-858d-45c721fe98dd/cd346cd3-6c1f-4dca-bfad-555d89b80e6c/3000x3000/nypreputationpodcastheroimage1400x1400042226_2.jpg?aid=rss_feed","author":"NewYork-Presbyterian","episode_count":65,"summary":"On Advances in Care, epidemiologist and science communicator Erin Welsh sits down with physicians from NewYork-Presbyterian hospital to discuss the details behind cutting-edge research and innovative treatments that are changing the course of medicine. From breakthroughs in genome sequencing to the backstories on life-saving cardiac procedures, the work of these doctors from Columbia & Weill Cornell Medicine is united by a collective mission to shape the future of health care and transform the lives of their patients. Erin Welsh, who also hosts This Podcast Will Kill You, gets to the heart of her guests’ most challenging and inventive medical discoveries. Advances in Care is a show for health careprofessionals and listeners who want to stay at the forefront of the latest medical innovations and research. Tune in to learn more about some of medicine’s greatest leaps forward. For more information visit nyp.org/Advances","last_synced_at":"2026-09-03T18:18:15.177380+00:00","page_url":"https://stenobird.com/podcast/advances-in-care-6039100"},"episode":{"title":"A Novel Immune-Based Cell Therapy Improves Treatment for Metastatic Melanoma","slug":"a-novel-immune-based-cell-therapy-improves-treatment-for-metastatic-melanoma","published_at":"2026-07-09T09:00:00+00:00","page_url":"https://stenobird.com/podcast/advances-in-care-6039100/a-novel-immune-based-cell-therapy-improves-treatment-for-metastatic-melanoma","show_page_url":"https://stenobird.com/podcast/advances-in-care-6039100","url":"https://advances-in-care.simplecast.com/episodes/a-novel-immune-based-cell-therapy-improves-treatment-for-metastatic-melanoma-OD5N7gcn","audio_url":"https://p.podderapp.com/1440337256/cdn.simplecast.com/media/audio/transcoded/20f5dff1-c9dc-44ab-8b84-fc16c4ca51b2/cc9697ff-ec07-4499-8331-0e85c7cccb15/episodes/audio/group/0ec9bf88-25e2-40f4-b1ae-2f0b93b5e1ca/group-item/cda164ff-d868-4af0-833e-24d5ef5792ac/128_default_tc.mp3?aid=rss_feed&feed=TZu4B0z0","summary":"On this episode of Advances in Care, Erin Welsh is joined by Dr. Barbara Ma, a medical oncologist at NewYork-Presbyterian who leads Cellular Therapy for Solid Tumors at Weill-Cornell Medicine. Dr. Ma and her team are at the forefront of utilizing a new therapy in the treatment of metastatic melanoma called tumor-infiltrating lymphocyte therapy—or TIL therapy—which received FDA approval in 2024. Patients receiving TIL therapy have seen tumors shrink in as little as one week after their first round of treatment. Dr. Ma discusses how her team is working to optimize TIL therapy by shortening the manufacturing process and reducing treatment-related toxicity to improve the patient experience. NewYork-Presbyterian and Weill Cornell Medicine is one of only a handful of medical centers to provide TIL therapy based on the complexity of this treatment approach, and also lead new research efforts to expand its potential for treating solid tumor cancers.","meta_description":"On this episode of Advances in Care, Erin Welsh is joined by Dr. Barbara Ma, a medical oncologist at NewYork-Presbyterian who leads Cellular Therapy for S…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1129,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/advances-in-care-6039100/episodes/a-novel-immune-based-cell-therapy-improves-treatment-for-metastatic-melanoma/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/advances-in-care-6039100/a-novel-immune-based-cell-therapy-improves-treatment-for-metastatic-melanoma.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}